HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dariusz Kowalski Selected Research

Dariusz Kowalski Research Topics

Disease

16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 01/2008
7Neoplasms (Cancer)
03/2024 - 08/2010
3Malignant Mesothelioma
01/2022 - 01/2017
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2017
2Heart Failure
01/2021 - 01/2017
2Brain Neoplasms (Brain Tumor)
01/2021 - 01/2021
2Disease Progression
01/2021 - 01/2020
2Lung Neoplasms (Lung Cancer)
01/2020 - 11/2018
1Melanoma (Melanoma, Malignant)
01/2022
1Microsatellite Instability
01/2022
1Adenoid Cystic Carcinoma (Cylindroma)
10/2021
1Encephalitis (Encephalitis, Rasmussen)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Adenocarcinoma of Lung
01/2020
1Adenocarcinoma
01/2020
1Chest Pain (Chest Pains)
01/2020
1Cough
01/2020
1Dyspnea (Shortness of Breath)
01/2020
1Edema (Dropsy)
01/2020
1Neutropenia
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2019
1Neoplasm Metastasis (Metastasis)
11/2018
1Respiratory Insufficiency (Respiratory Failure)
01/2017
1Colitis
01/2017
1Myocardial Infarction
01/2017
1Mesothelioma
01/2017
1Infections
01/2017

Drug/Important Bio-Agent (IBA)

5ErbB Receptors (EGF Receptor)IBA
03/2024 - 11/2020
3osimertinibIBA
03/2024 - 01/2020
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 08/2010
2PlatinumIBA
01/2023 - 01/2020
2IpilimumabIBA
01/2022 - 01/2021
2Monoclonal AntibodiesIBA
01/2022 - 01/2017
2NivolumabIBA
01/2022 - 01/2021
2Vinorelbine (Navelbine)FDA LinkGeneric
01/2021 - 08/2010
2AfatinibIBA
01/2021 - 01/2021
2Tyrosine Kinase InhibitorsIBA
11/2020 - 01/2020
2Docetaxel (Taxotere)FDA Link
01/2020 - 11/2014
2Carboplatin (JM8)FDA LinkGeneric
01/2020 - 01/2019
1atezolizumabIBA
01/2023
1LigandsIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1triplex DNA (H-DNA)IBA
01/2022
1GemcitabineFDA Link
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1STA 9090IBA
01/2020
1tepotinibIBA
01/2020
1130-nm albumin-bound paclitaxelIBA
01/2020
11- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
01/2020
1pembrolizumabIBA
01/2020
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020
1Paclitaxel (Taxol)FDA LinkGeneric
01/2020
1B7-H1 AntigenIBA
01/2020
1Etoposide (VP 16)FDA LinkGeneric
01/2019
1roniciclibIBA
01/2019
1MicroRNAs (MicroRNA)IBA
07/2017
1tremelimumabIBA
01/2017
1CTLA-4 AntigenIBA
01/2017
1SurvivinIBA
11/2014
1LY 2181308IBA
11/2014
1Antisense OligonucleotidesIBA
11/2014

Therapy/Procedure

7Therapeutics
07/2023 - 01/2017
6Drug Therapy (Chemotherapy)
01/2023 - 01/2008
4Immunotherapy
01/2023 - 01/2017
3Radiotherapy
10/2021 - 08/2010
1Adjuvant Chemotherapy
07/2023
1Salvage Therapy
01/2020
1Chemoradiotherapy
08/2010
1Molecular Targeted Therapy
01/2008